JP2010525055A5 - - Google Patents

Download PDF

Info

Publication number
JP2010525055A5
JP2010525055A5 JP2010506110A JP2010506110A JP2010525055A5 JP 2010525055 A5 JP2010525055 A5 JP 2010525055A5 JP 2010506110 A JP2010506110 A JP 2010506110A JP 2010506110 A JP2010506110 A JP 2010506110A JP 2010525055 A5 JP2010525055 A5 JP 2010525055A5
Authority
JP
Japan
Prior art keywords
corm
medicament
manufacture
treatment
infectious diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2010506110A
Other languages
English (en)
Other versions
JP2010525055A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/PT2008/000017 external-priority patent/WO2008130261A1/en
Publication of JP2010525055A publication Critical patent/JP2010525055A/ja
Publication of JP2010525055A5 publication Critical patent/JP2010525055A5/ja
Pending legal-status Critical Current

Links

Claims (1)

  1. 感染症の処置用の医薬の製造における、ＣＯＲＭの使用。
JP2010506110A 2007-04-24 2008-04-24 一酸化炭素による感染症の処置 Pending JP2010525055A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US92597607P 2007-04-24 2007-04-24
PCT/PT2008/000017 WO2008130261A1 (en) 2007-04-24 2008-04-24 Treatment of infections by carbon monoxide

Publications (2)

Publication Number Publication Date
JP2010525055A JP2010525055A (ja) 2010-07-22
JP2010525055A5 true JP2010525055A5 (ja) 2012-06-28

Family

ID=39720470

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010506110A Pending JP2010525055A (ja) 2007-04-24 2008-04-24 一酸化炭素による感染症の処置

Country Status (4)

Country Link
US (1) US20100196516A1 (ja)
EP (1) EP2148688A1 (ja)
JP (1) JP2010525055A (ja)
WO (1) WO2008130261A1 (ja)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0111872D0 (en) 2001-05-15 2001-07-04 Northwick Park Inst For Medica Therapeutic agents and methods
US7968605B2 (en) 2002-02-04 2011-06-28 ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. Methods for treating inflammatory disease by administering aldehydes and derivatives thereof
AU2003208525B9 (en) 2002-02-04 2009-08-27 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Amend the invention title to read Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
GB2395432B (en) 2002-11-20 2005-09-14 Northwick Park Inst For Medica Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs
JP2007501209A (ja) * 2003-08-04 2007-01-25 ノースウィック パーク インスティテュート フォー メディカル リサーチ 一酸化炭素の治療目的での放出のためのボラノカルボネートの使用
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
GB0601394D0 (en) 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
JP5563452B2 (ja) * 2007-07-24 2014-07-30 アルファーマ−インベスティガシオ エ デセンボルビメント デ プロデュトス ファルマセウティコス エレデア． 一酸化炭素による胃潰瘍の予防
JP5978291B2 (ja) * 2011-04-19 2016-08-24 アルファーマ インコーポレイテッドＡｌｆａｍａ，Ｉｎｃ． 一酸化炭素放出分子およびその使用
ES2628634T3 (es) 2011-07-21 2017-08-03 Alfama, Inc. Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
DE102014008685A1 (de) * 2014-06-13 2015-12-17 Lorenz Meinel Freisetzungssystem für therapeutisches Gas
US10314860B2 (en) 2015-05-21 2019-06-11 Arizona Board Of Regents On Behalf Of The University Of Arizona Compositions and methods for treating and preventing venom related poisoning
WO2017015344A1 (en) * 2015-07-20 2017-01-26 University Of Vermont And State Agricultural College Use of cymanquine compounds as antimalarial agents
EP3524290A1 (en) 2018-02-09 2019-08-14 Julius-Maximilians-Universitaet Wuerzburg Method and system for monitoring carbon monoxide (co) administration to ex-vivo fluids
EP3808351A1 (en) 2019-10-14 2021-04-21 Julius-Maximilians-Universität Würzburg Membrane-based two component therapeutic gas release system for oral administration
EP3878471A1 (en) 2020-03-13 2021-09-15 Julius-Maximilians-Universitaet Wuerzburg Therapeutic system for the topic, transdermal and transcutaneous application of carbon monoxide
EP4275682A1 (en) * 2022-05-12 2023-11-15 Institut National De La Sante Et De La Recherche Medicale - Inserm Carbon monoxide-releasing molecule (corm) or composition thereof for use in the treatment or the prevention of an intestinal dysbiosis in a subject
WO2024052570A1 (en) 2022-09-09 2024-03-14 Julius-Maximilians-Universität Würzburg Method for the preservation of functional gametes

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3065250A (en) * 1960-05-13 1962-11-20 Hercules Powder Co Ltd Nitrile-metal carbonyl complexes
US4792452A (en) * 1987-07-28 1988-12-20 E. R. Squibb & Sons, Inc. Controlled release formulation
EP1381354A2 (en) * 2001-03-30 2004-01-21 Sangstat Medical Corporation Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders
AU2003208525B9 (en) * 2002-02-04 2009-08-27 Alfama-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda Amend the invention title to read Method for treating a mammal by administration of a compound having the ability to release CO, compounds having the ability to release CO and pharmaceutical compositions thereof
AU2003279236B8 (en) * 2002-06-21 2009-02-19 Beth Israel Deaconess Medical Center, Inc. Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
WO2004022629A2 (en) * 2002-09-09 2004-03-18 Nektar Therapeutics Al, Corporation Method for preparing water-soluble polymer derivatives bearing a terminal carboxylic acid
JP2007501209A (ja) * 2003-08-04 2007-01-25 ノースウィック パーク インスティテュート フォー メディカル リサーチ 一酸化炭素の治療目的での放出のためのボラノカルボネートの使用
US8148356B2 (en) * 2005-08-24 2012-04-03 Cumberland Pharmaceuticals, Inc. Acetylcysteine composition and uses therefor
WO2007073226A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda Method for treating a mammal by administration of a compound having the ability to release co
WO2007073225A1 (en) * 2005-12-20 2007-06-28 Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda. Molybdenum carbonyl complexes for treating rheumatoid arthritis and other inflammatory diseases
GB0601394D0 (en) * 2006-01-24 2006-03-01 Hemocorm Ltd Therapeutic delivery of carbon monoxide
AU2007328549A1 (en) * 2006-12-06 2008-06-12 Alfama - Investigacao E Desenvolvimento De Produtos Farmaceuticos Lda Methods for treating inflammatory disease by administering aldehydes and derivatives thereof

Similar Documents

Publication Publication Date Title
JP2010525055A5 (ja)
JP2014530840A5 (ja)
JP2007520565A5 (ja)
JP2009256391A5 (ja)
JP2013014622A5 (ja)
JP2010507682A5 (ja)
JP2009039101A5 (ja)
SMT201300007B (it) Trattamento di una malattia respiratoria
JP2011526809A5 (ja)
JP2012504217A5 (ja)
JP2015525757A5 (ja)
JP2006305390A5 (ja)
JP2011511805A5 (ja)
CL2008000461A1 (es) Uso de aclidinio en el tratamiento o prevencion de una enfermedad o un estado respiratorio en un paciente por inhalacion, sin producir en dicho paciente efectos antimuscarinicos sistemicos.
JP2013181136A5 (ja) ポリイミド前駆体組成物、ポリイミド成形体、及び画像形成装置
JP2008519810A5 (ja)
JP2009215191A5 (ja)
JP2012501683A5 (ja)
JP2012516348A5 (ja)
JP2011503050A5 (ja)
JP2009001575A5 (ja)
ME01951B (me) Upotreba agomelatina za dobijanje lekova namenjenih tretmanu bipolarnih poremećaja
IL216717A (en) Use of benzidamine in the manufacture of a drug for the treatment of p40-dependent diseases
JP2011529851A5 (ja)
RU2005128615A (ru) Средство для лечения заболеваний пародонта